659722-69-7

Upstream product

• 607707-96-0 (3aR,4R,7S,7aR)-5-(4'-ethoxyethoxy-benzenesulfonyl)-7-hydroxy-2,2-dimethyl-hexahydro-[1,3]dioxolo[4,5-c]pyridine-4-carboxylic acid methyl ester 
• 607707-90-4 (1S,2R,4'R,5'R)-[5'-(1,2-dihydroxyethyl)-2',2'-dimethyl-[1,3]dioxolan-4'-yl]-[4-(ethoxyethoxy)benzenesulfonylamino]-acetic acid methyl ester 
• 607707-87-9 (2R,4'S,4S,5'R)-[4-(ethoxyethoxy)benzenesulfonylamino]-(2',2',2,2-tetramethyl-[4',4]bis[[1,3]dioxolanyl]-5'-yl)-acetic acid methyl ester 
• 607707-93-7 (1S,2R,4'R,5'R)-[4-(ethoxyethoxy)benzenesulfonylamino]-[5'-(1-hydroxy-2-methanesulfonyloxy-ethyl)-2',2'-dimethyl-[1,3]dioxolan-4'-yl]-acetic acid methyl ester 
• 2687-43-6 O-benzylhydoxylamine hydrochloride 

Downstream Products

• 607708-00-9 (2R,3R,4R,5S)-1-(4'-ethoxyethoxybenzenesulfonyl)-3,4,5-trihydroxy-piperidine-2-carboxylic acid benzyloxyamide 

Relevant academic research and scientific papers

Structure-activity relationships of azasugar-based MMP/ADAM inhibitors

In order to investigate structure-activity relationships of azasugar series toward metalloproteinases, we synthesized and evaluated several azasugar-based compounds. As a result, it was found that 4-phenoxybenzene derivative 3 having 2R,3R,4R,5S-configura